REMEDi4ALL

REMEDi4ALL Clinical Trials Webinar Series: Support and Management of Clinical Trials
2025-03-07 11:00 - 12:30 (Europe/Amsterdam) | Online Event
Register for Webinar 3 here!

Webinar 3: Support and Management of Clinical Trials – 7 March (11:00-12:30 CET)
Exploring different organisations, processes and pathways for expert support when planning, setting up and running a clinical trial.
In this third and final webinar in the series we will highlight different collaborations that are required in running a clinical trial efficiently. Find out more here!

REMEDi4ALL Drug Repurposing Bootcamp for Academics
2025-03-17 - 2025-03-18 | Hinxton Hall, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1RQ, United Kingdom
Drug repurposing offers a faster, more cost-effective way to develop treatments, addressing urgent patient needs and unlocking opportunities for academic innovation. However, the journey from a repurposing concept to a market-ready product is complex, presenting significant challenges for researchers. The REMEDi4ALL Drug Repurposing Bootcamp for Academics is designed to support senior post-doctoral researchers and early-career principal investigators leading promising projects by equipping them with the skills and knowledge to navigate this pathway successfully.
This immersive, day-and-a-half training programme combines expert lectures, interactive discussions, and working groups to cover key topics such as regulatory engagement, collaboration building, funding applications, and science communication. By participating, attendees will not only develop a clearer understanding of how to deliver real patient impact but also join the growing REMEDi4ALL community.
Twenty fully funded places are available, covering travel, accommodation, and access to this free training. Applications are open until February, with reviews conducted on a rolling basis.
Find out more information here: REMEDi4ALL Drug Repurposing Bootcamp for Academics
Register here!

Unlocking research opportunities: Partnering with academics
2025-04-01 12:00 - 13:30 | Online Event
Are you looking to engage in research but don’t know where to start?
Research is a key priority for many patient groups but connecting with the right academic partners is not often straightforward. With limited awareness of rare conditions in academia, knowing where to start, initiating conversations, and building lasting relationships with the right research teams can be challenging.
What will you learn in this webinar?

How academic research works and the structures that shape it
Where to find researchers working on your condition and how to connect with them
Practical ways to boost the appeal of your patient group to researchers
A real-world example of a patient group successfully partnering with academics and getting involved in research

For more information visit the event page here.

REMEDi4ALL Funders Network Event 2025
2025-05-06 | Royal Netherlands Academy of Arts and Sciences (KNAW), Het Trippenhuis, Kloveniersburgwal 29, 1011 JV, Amsterdam, 1011 JV, Netherlands
Pre-iDR25 REMEDi4ALL Funders Network Event
In an exclusive pre-conference meeting, members and observers of the REMEDi4ALL Funders Network will come together to share best practices and discuss important topics. This meeting will be followed by an evening boat trip on the Amsterdam canals and a Funders Network dinner at IJver restaurant.
Register here!

Meeting location: Royal Netherlands Academy of Arts and Sciences (KNAW), Het Trippenhuis, Kloveniersburgwal 29, Amsterdam
Dinner location: IJver Restaurant, Scheepsbouwkade 72, Amsterdam

#iDR25 Pre-Conference Workshops
2025-05-06 12:00 - 18:30 | Royal Netherlands Academy of Arts and Sciences (KNAW), Het Trippenhuis, Kloveniersburgwal 29, 1011 JV, Amsterdam, 1011 JV, Netherlands
To kick off the iDR25 conference series, two exclusive pre-conference workshops will be held on 6th May 2025 at the Royal Netherlands Academy of Arts and Sciences (KNAW). The workshops are primarily aimed at academics, early career researchers and patient representatives looking to increase the understanding of key topics related to medicines repurposing and gain practical skills to apply to current and future drug repurposing projects.
Register today for the pre-iDR25 workshop series!

Workshop 1: Health Technology Assessment: a key tool to patient access
Tuesday 6th May 2025
12:30-14:30

After regulatory approval by the EMA, Health Technology Assessment (HTA) becomes a pivotal process in determining whether new treatments will be accessible to patients, influencing their affordability, availability, and overall impact on healthcare systems. The HTA dossier encapsulates critical information, including the medical, economic, social, and ethical considerations of using a health technology—such as a repurposed medicine. Prepared by the product developer or sponsor, these dossiers undergo evaluation by HTA agencies, like EUnetHTA 21 in the EU or NICE in the UK, to assess their value and feasibility.
This workshop will equip researchers, patient representatives and product developers with the knowledge and tools to design their repurposing projects to meet HTA standards from the onset. With a focus on early alignment with HTA requirements, evidence planning, and incorporating patient engagement into the HTA process from the beginning, attendees will gain actionable insights to streamline their projects through HTA evaluations, enhancing the likelihood of timely patient access.
This workshop offers a unique opportunity to learn proactive strategies to maximise the success of drug repurposing projects in achieving their ultimate goal—reaching and benefiting patients.

Workshop 2: Navigating the regulatory path for medicinal product repurposing
Tuesday 6th May 2025
15:00-18:30

In this workshop, we will discuss the regulatory path and key milestones for advancing a repurposed/repositioned medicinal product from preclinical development to market authorisation in Europe, tailored for academic researchers and early-career developers navigating such processes for the first time. Whether you are preparing for your first clinical trial application or strategising for market authorisation, this session will provide crucial tools and insights to help build your regulatory strategy including:

Core elements of a Clinical Trial Application (CTA)
Obtaining Orphan Drug Designations for rare diseases
Effective engagement with regulatory authorities (e.g. scientific advice)
Overview of possible registration pathways to bring promising therapies to patients faster
Building the Common Technical Document (CTD) for a European Marketing Authorisation Application (MAA)

Confirmed speakers

Register today for the pre-iDR25 workshop series!

Note: this event is separate to the main conference. Find out more about iDR25: Medicines Reimagined here.
Questions? Contact conference@remedi4all.org.

International Drug Repurposing Conference 2025 - #iDR25
2025-05-07 - 2025-05-08 | Amsterdam, the Netherlands
Exciting news for anyone passionate about healthcare innovation—iDR25, the International Drug Repurposing Conference, is coming up on 7-8th May 2025 in the beautiful city of Amsterdam in The Netherlands!

Recurrent Respiratory Papillomatosis (RRP) Awareness Day Webcast
2025-06-11 19:00 - 20:30 | Online Event
RRP Awareness Day is an international event to raise awareness about recurrent respiratory papillomatosis (RRP), a debilitating disease driven by chronic HPV 6/11 viral infection.
Join the RRP Awareness Day global webcast on June 11th to hear from RRP patients, their caregivers, and the healthcare community supporting them about:

Patient and caregiver experience with RRP
Significant burden of living with RRP
Challenges of repeated surgeries and risk of irreversible injury
Need for new innovations

CO-HOSTS

RRP Foundation
Kim McClellan, President

PRECIGEN
Helen Sabzevari, PhD, President and CEO

Who should attend?

RRP patients
Caregivers and family members
Healthcare providers
Community supporting RRP patients

Webinar: Cures Within Reach new funding call: Clinical trials to validate AI-driven drug repurposing
2025-07-31 16:30 - 17:30 | Online Event
Artificial intelligence (AI) is increasingly seen as a powerful tool in the search for new treatments – especially through drug repurposing. By analysing large sets of data, AI can help identify existing medicines that might work for different conditions – something particularly valuable in rare diseases.
However, do AI-generated predictions actually work when tested in real-life clinical trials?
Cures Within Reach is helping to explore this question through a new funding call. They’re inviting letters of intent for Phase I/IIA clinical trials that will test and validate AI-based repurposing ideas, with a preference for rare disease.
Learn more about the call here.

This webinar hosted by Beacon for Rare Diseases in collaboration with REMEDi4ALL and Cures within Reach will cover:

A breakdown of what this funding call is about
Advice from Cures Within Reach on what makes a strong application
How patient groups can get involved in applications
A practical example of a patient group contributing to an AI-led initiative
The opportunity to ask any questions you might have to the Cures Within Reach team

Register for the webinar here!

2025 REMEDi4ALL Hackathon
2025-10-06 14:00 - 2025-10-10 17:00 | Hotel Checkin Montserrat, Carrer Querol, 08293 Collbató, Barcelona, Spain
Are you an early career researcher (ECR) who wants to delve into drug repurposing?

Join us for the second REMEDi4ALL Hackathon, 6-10 October 2025, held at Hotel Checkin Montserrat, near Barcelona, Spain.
The REMEDi4ALL Repurposing Hackathon is designed to help early career researchers learn by doing. Join a small team of international trainees keen to learn about the repurposing pathway on a week-long residential course where you aim to plan the development of a repurposing candidate for a specific patient community.
Who is the Hackathon for?

Students and researchers in the early stages of their career up to 2 years post-doc
Individuals with an interest in drug repurposing
Individuals with an excellent scientific track record
Previous experience in the drug repurposing field will be considered a plus

What will you learn?
The REMEDi4ALL Hackathon aims to teach participants how to:

Use computational tools to generate repurposing candidates suitable for a defined indication
Narrow down potential repurposed drug options tailored to a particular indication
Identify needs and knowledge gaps in a repurposing project, helping to define the path for a drug candidate
Work together with other ECRs to complete a repurposing challenge

Training format

In-person, residential training for 15 participants
Advance registration required
Small teams of early career researchers work on a project throughout the week
Support through lectures and guidance of REMEDi4ALL experts, and external advisers, including patient experts

Interested in learning more? Check out our highlights video from 2024 or explore the Hackathon website within the REMEDi4ALL Repurposing Academy.

Webinar: IP Strategies for Repurposing
2025-11-21 14:00 - 15:30 | Online Event
Discover the value of having an intellectual property (IP) strategy in your repurposing project and how to use this to drive success!
Not sure where to start with intellectual property (IP) in your drug repurposing project? REMEDi4ALL’s Repurposing Academy is here to guide you!
Join us for our upcoming webinar where we will explore the importance of considering IP as part of your broader drug repurposing strategy.
We’ll discuss common challenges you may encounter and key considerations to keep in mind throughout your repurposing project. Additionally, we’ll outline practical steps for securing IP protection for repurposed drugs and show how a strong IP strategy can help drive your project forward.

ProvenConnect REMEDi4ALL Webinar
2025-11-27 13:00 - 14:00 | Online Event
* This is an online event that will take place 1200–1300 UK time (1300-1400 CET) on Zoom. *
REMEDi4ALL is presenting to the TAR Network in a Proven Connect webinar. Speakers Alicia Soler (Lead Scientific Operations at REMEDi4ALL /EATRIS), Heleen van der Meer (Senior programme manager international drug repurposing at ZonMw) and Pan Pantziarka (Director of Drug Repurposing at Anticancer Fund) will present the REMEDi4ALL project and Funder’s Network.

REMEDi4ALL Funders Network Event 2026
2026-05-11 | Maison de la Poste, Brussels, Belgium, Rue Picard 7, Brussels, Belgium
Pre-iDR26 REMEDi4ALL Funders Network Event
As in previous editions, #iDR26 will feature a pre-conference meeting dedicated to the Funders Network on Monday 11 May.
During this meeting, funders will:

discuss important topics, including innovative co-funding models,
share best funding practices,
enjoy a networking lunch, and
conclude the day with drinks & bites.

The meeting is open to all members of the Funders Network. Register here for the meeting (limited places available)!
Are you a funder who is not yet a member but interested in joining? Contact us at remedi4all@zonmw.nl.

International Drug Repurposing Conference 2026 - #iDR26
2026-05-12 - 2026-05-13 | Maison de la Poste, Brussels, Belgium, Rue Picard 7, Brussels, Belgium
Join iDR26, the International Drug Repurposing Conference, on 12-13 May 2026 in Brussels, Belgium to explore the future of patient-centric medicines repurposing.
From rare diseases and AI-driven drug discovery, to policy, funding and community-led success stories, iDR26 brings together the global drug repurposing community to navigate the next chapter in maximising patient benefit.
Explore the full conference here!
